ReP USP - Resultado da busca

Artigo de periodico
PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency (2020)
Montaldi, Ana P.; Lima, Sarah Caroline Gomes de ; Godoy, Paulo Roberto D'Auria Vieira; Xavier, Danilo Jordão; Sakamoto-Hojo, Elza Tiemi
Source: Oncology Reports. Unidades: FFCLRP, FMRP
Subjects: ANTINEOPLÁSICOS, FARMACOLOGIA, APOPTOSE, NEOPLASIAS CEREBRAIS, PATOLOGIA, GLIOMA, METABOLISMO, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTALDI, Ana P. et al. PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency. Oncology Reports, v. 44, n. 5, p. 2275-2287, 2020Tradução . . Disponível em: https://doi.org/10.3892/or.2020.7756. Acesso em: 03 jun. 2024.
APA
Montaldi, A. P., Lima, S. C. G. de, Godoy, P. R. D. 'A. V., Xavier, D. J., & Sakamoto-Hojo, E. T. (2020). PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency. Oncology Reports, 44( 5), 2275-2287. doi:10.3892/or.2020.7756
NLM
Montaldi AP, Lima SCG de, Godoy PRD'AV, Xavier DJ, Sakamoto-Hojo ET. PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency [Internet]. Oncology Reports. 2020 ; 44( 5): 2275-2287.[citado 2024 jun. 03 ] Available from: https://doi.org/10.3892/or.2020.7756
Vancouver
Montaldi AP, Lima SCG de, Godoy PRD'AV, Xavier DJ, Sakamoto-Hojo ET. PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency [Internet]. Oncology Reports. 2020 ; 44( 5): 2275-2287.[citado 2024 jun. 03 ] Available from: https://doi.org/10.3892/or.2020.7756
Artigo de periodico
APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line (2015)
Montaldi, Ana P.; Godoy, Paulo R. D. V.; Sakamoto-Hojo, Elza Tiemi
Source: Mutation Research-Genetic Toxicology and Environmental Mutagenesis. Unidade: FFCLRP
Subjects: NEOPLASIAS CEREBRAIS, GENÉTICA, QUIMIOTERÁPICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTALDI, Ana P. e GODOY, Paulo R. D. V. e SAKAMOTO-HOJO, Elza Tiemi. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line. Mutation Research-Genetic Toxicology and Environmental Mutagenesis, v. 793, p. 19-19, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.mrgentox.2015.06.001. Acesso em: 03 jun. 2024.
APA
Montaldi, A. P., Godoy, P. R. D. V., & Sakamoto-Hojo, E. T. (2015). APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line. Mutation Research-Genetic Toxicology and Environmental Mutagenesis, 793, 19-19. doi:10.1016/j.mrgentox.2015.06.001
NLM
Montaldi AP, Godoy PRDV, Sakamoto-Hojo ET. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line [Internet]. Mutation Research-Genetic Toxicology and Environmental Mutagenesis. 2015 ; 793 19-19.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.mrgentox.2015.06.001
Vancouver
Montaldi AP, Godoy PRDV, Sakamoto-Hojo ET. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line [Internet]. Mutation Research-Genetic Toxicology and Environmental Mutagenesis. 2015 ; 793 19-19.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.mrgentox.2015.06.001
Artigo de periodico
Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide (2013)
Montaldi, Ana P.; Sakamoto-Hojo, Elza Tiemi
Source: Clinical and Experimental Medicine. Unidade: FFCLRP
Subjects: NEOPLASIAS CEREBRAIS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTALDI, Ana P. e SAKAMOTO-HOJO, Elza Tiemi. Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide. Clinical and Experimental Medicine, v. 13, n. 4, p. 279-288, 2013Tradução . . Disponível em: https://doi.org/10.1007/s10238-012-0201-x. Acesso em: 03 jun. 2024.
APA
Montaldi, A. P., & Sakamoto-Hojo, E. T. (2013). Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide. Clinical and Experimental Medicine, 13( 4), 279-288. doi:10.1007/s10238-012-0201-x
NLM
Montaldi AP, Sakamoto-Hojo ET. Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide [Internet]. Clinical and Experimental Medicine. 2013 ; 13( 4): 279-288.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s10238-012-0201-x
Vancouver
Montaldi AP, Sakamoto-Hojo ET. Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide [Internet]. Clinical and Experimental Medicine. 2013 ; 13( 4): 279-288.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s10238-012-0201-x
Artigo de periodico
Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors (2009)
Brassesco, María S.; Montaldi, Ana P.; Gras, Diana E.; Camparoto, Marjori L.; Martinez-Rossi, Nilce Maria; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Sakamoto-Hojo, Elza Tiemi
Source: Mutagenesis. Unidades: FMRP, FFCLRP
Subjects: CITOGENÉTICA, LINFÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, María S. et al. Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors. Mutagenesis, v. 24, n. 2, p. 153-160, 2009Tradução . . Disponível em: https://doi.org/10.1093/mutage/gen063. Acesso em: 03 jun. 2024.
APA
Brassesco, M. S., Montaldi, A. P., Gras, D. E., Camparoto, M. L., Martinez-Rossi, N. M., Scrideli, C. A., et al. (2009). Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors. Mutagenesis, 24( 2), 153-160. doi:10.1093/mutage/gen063
NLM
Brassesco MS, Montaldi AP, Gras DE, Camparoto ML, Martinez-Rossi NM, Scrideli CA, Tone LG, Sakamoto-Hojo ET. Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors [Internet]. Mutagenesis. 2009 ; 24( 2): 153-160.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1093/mutage/gen063
Vancouver
Brassesco MS, Montaldi AP, Gras DE, Camparoto ML, Martinez-Rossi NM, Scrideli CA, Tone LG, Sakamoto-Hojo ET. Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors [Internet]. Mutagenesis. 2009 ; 24( 2): 153-160.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1093/mutage/gen063

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em